Company intelligence / Profile preview

SinoBiomed

Beijing, Beijing, Chinasinobiological.com ↗

Ownership: Private
Employees: ~900
Development stage: Commercial

Overview

Sino Biological supplies high-quality recombinant proteins, antibodies, cDNA clones, ELISA kits, cell culture media, and related CRO services to academic institutions, biotech firms, pharmaceutical companies, and diagnostic developers worldwide. It specializes in large-scale reagent manufacturing with advanced quality control systems. The company recently expanded by acquiring SignalChem Biotech Inc., further strengthening its global presence.

Modalities: Recombinant proteinAntibodycDNA clone production
Industry: Chemicals & Materials

Beyond the preview

Go deeper on SinoBiomed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SinoBiomed.

Explore the full profile